Poulikos I. Poulikakos

Biochemistry, Genetics and Molecular BiologyComputer ScienceChemistryMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 12 papers. Top paper: “Bridged Proteolysis Targeting Chimera (PROTAC) Enables Degradation of Undruggable Targets”.

Bridged Proteolysis Targeting Chimera (PROTAC) Enables Degradation of Undruggable Targets

Journal of the American Chemical Society(2022)10.1021/jacs.2c09255

N/A

0.736DataRank · unranked

134 citations

Yue Zhong, Hyerin Yim, Xiaobao Yang, Kwang‐Su Park, Ling Xie +7 more

Distinct CDK6 complexes determine tumor cell response to CDK4/6 inhibitors and degraders

Nature Cancer(2021)10.1038/s43018-021-00174-z

N/A

0DataRank · unranked

73 citations

Xiaobao Yang, Yan Xiong, Ruitong Li, Takahiro Ito, Tamer A. Ahmed +14 more

AKT Degradation Selectively Inhibits the Growth of PI3K/PTEN Pathway–Mutant Cancers with Wild-Type KRAS and BRAF by Destabilizing Aurora Kinase B

Cancer Discovery(2021)10.1158/2159-8290.cd-20-0815

N/A

0DataRank · unranked

66 citations

Xufen Yu, Tiphaine Martin, Ankita Bansal, Kakit Cheung, Abigail Lubin +15 more

Exploiting Allosteric Properties of RAF and MEK Inhibitors to Target Therapy-Resistant Tumors Driven by Oncogenic BRAF Signaling

Cancer Discovery(2021)10.1158/2159-8290.cd-20-1351

N/A

0DataRank · unranked

65 citations

Tamer A. Ahmed, Maxwell R. Tucker, Peter M.U. Ung, Min Xiao, Zoi Karoulia +12 more

CDK4: a master regulator of the cell cycle and its role in cancer

Genes & Cancer(2022)10.18632/genesandcancer.221

N/A

0DataRank · unranked

85 citations

Poulikos I. Poulikakos, Hanna Y. Irie, Samir Parekh, E. Premkumar Reddy, Stacey J. Baker

RETRACTED ARTICLE: ROCK1 mechano-signaling dependency of human malignancies driven by TEAD/YAP activation

Nature Communications(2022)10.1038/s41467-022-28319-3

N/A

0DataRank · unranked

55 citations

Ila Pant, Yao Shen, Rui Fang Qiao, Xiaobao Yang, Yiyang Bai +4 more

Data from Exploiting Allosteric Properties of RAF and MEK Inhibitors to Target Therapy-Resistant Tumors Driven by Oncogenic BRAF Signaling

(2023)10.1158/2159-8290.c.6549364

N/A

0DataRank · unranked

1 citations

Tamer A. Ahmed, Maxwell R. Tucker, Peter M.U. Ung, Min Xiao, Zoi Karoulia +12 more

Mechanism of dimer selectivity and binding cooperativity of BRAF inhibitors

eLife(2024)10.7554/elife.95334

N/A

0DataRank · unranked

1 citations

Aarion Romany, Evangelia Matenoglou, Evripidis Gavathiotis, Poulikos I. Poulikakos, Zhong‐Yin Zhang +1 more

Resistance mechanisms and therapeutic strategies of CDK4 and CDK6 kinase targeting in cancer

Nature Cancer(2025)10.1038/s43018-024-00893-z

N/A

0DataRank · unranked

46 citations

Xuewei Wu, Christos Adamopoulos, Evripidis Gavathiotis, Poulikos I. Poulikakos, James J. Asciolla

Mechanism of dimer selectivity and binding cooperativity of BRAF inhibitors

eLife(2025)10.7554/elife.95334.4

N/A

0DataRank · unranked

5 citations

Aarion Romany, Evangelia Matenoglou, Evripidis Gavathiotis, Poulikos I. Poulikakos, Zhong‐Yin Zhang +1 more

Inhibitors of BRAF dimers using an allosteric site

Nature Communications(2020)10.1038/s41467-020-18123-2

N/A

0DataRank · unranked

86 citations

Bogos Agianian, Nadege Gitego, Emmanouil Zacharioudakis, Orsi Giricz, Yang Wu +5 more

Recent Developments in Targeting the Cell Cycle in Melanoma

Cancers(2025)10.3390/cancers17081291

N/A

0DataRank · unranked

4 citations

Trang Nguyen, Poulikos I. Poulikakos, David Polsky, Christie Hung